查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1675570

2025年全球医院感染控制市场报告

Hospital-Acquired Infection Control Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年医院感染控制市场规模将强劲成长。它将以 5.5% 的年复合成长率（CAGR）增长至 2029 年的 444.2 亿美元。预测期内的成长可归因于多重抗药性病原体的增加、大流行病防范、加强监测和监控、抗菌药物管理计划和国际合作。预测期内的关键趋势包括采用即时定位系统 (RTLS)、整合人工智慧 (AI) 进行监控、转向一次性和一次性设备、重视员工培训和教育以及增加使用消毒技术。

由于 COVID-19 病例的突然增加，医院感染控制市场预计将出现成长。由 SARS-CoV-2 病毒引起的 COVID-19 引起了人们对个人卫生和医疗用品生产的重视，从而导致对感染控制产品和服务的需求增加。根据世界卫生组织（WHO）的数据，截至2022年8月8日，全球COVID-19感染人数已达5.816亿，证实了持续的疫情导致市场扩张。

预计医疗保健支出的增加将推动医院感染控制市场的成长。医疗保健支出包括在规定时限内医疗保健服务、产品和活动的总支出，无论是在个人、地区、国家或全球层面。随着医疗支出的增加，医院和医疗机构可能会分配更多资源来实施先进的感染预防技术​​。这包括先进的消毒系统、智慧监控设备和其他增强整体感染控制的技术等创新解决方案。例如，2024 年 5 月，英国政府机构国家统计局报告称，2022 年至 2023 年，医疗保健总支出名义上将增加 5.6%（2022 年仅成长 0.9%）。因此，医疗保健支出的增加将在未来几年推动医院感染控制市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情境 宏观经济情境包括利率、通膨、地缘政治、新冠疫情和市场復苏的影响

第五章 全球成长分析与策略分析框架

  • 全球医院感染控制PESTEL分析（政治、社会、科技、环境、法律、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球医院感染控制市场：成长率分析
  • 全球医院感染控制市场表现：规模与成长，2019-2024
  • 全球医院感染控制市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球医院感染控制总目标市场（TAM）

第六章市场区隔

  • 全球医院感染控制市场：依产品、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 消毒器
  • 消毒剂
  • 内视镜再处理装置
  • 微生物检测设备
  • 耗材
  • 消毒剂
  • 感染预防及监测软体
  • 其他产品
  • 全球医院感染控制市场：依技术、绩效与预测，2019-2024 年、2024-2029 年、2034 年
  • 表型分析
  • 基因分型方法
  • 全球医院感染控制市场（依疾病、绩效及预测）：2019-2024 年、2024-2029 年、2034 年
  • 医院获得性肺炎
  • 血流感染疾病
  • 手术部位感染
  • 胃肠道感染疾病
  • 尿道感染
  • 其他疾病
  • 全球医院感染控制市场：应用、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 疾病检测
  • 抗药性检测
  • 全球医院感染控制市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 加护病房
  • 门诊手术
  • 诊断中心
  • 疗养院
  • 产科中心
  • 其他最终用户
  • 全球医院感染控制市场依灭菌器类型、效能及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 蒸气灭菌器
  • 环氧乙烷灭菌器
  • 过氧化氢灭菌器
  • 全球医院感染控制市场，按消毒剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 清洗消毒机
  • 自动消毒设备
  • 全球医院感染控制市场按内视镜再处理器类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 高水准消毒后处理设备
  • 内视镜自动再处理装置
  • 全球医院感染控制市场按微生物检测设备类型细分、绩效及预测（2019-2024 年、2024-2029 年预测、2034 年预测）
  • 文化体系
  • 快速微生物检测系统
  • 全球医院感染控制市场按耗材类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 灭菌包
  • 过滤器
  • 个人防护设备（PPE）
  • 全球医院感染控制市场，按消毒剂类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 酒精消毒剂
  • 含氯消毒剂
  • 季铵化合物
  • 全球医院感染控制市场，依感染预防及监测软体类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 监控软体解决方案
  • 资料管理软体
  • 全球医院感染控制市场，依其他产品细分，依类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 清洁设备
  • 空气清净系统

第七章 区域和国家分析

  • 全球医院感染控制市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球医院感染控制市场：依国家、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 医院感染控制市场：竞争格局
  • 医院感染控制市场：公司简介
    • Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • P&G Professional Overview, Products and Services, Strategy and Financial Analysis
    • Honeywell International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • MMM Group Overview, Products and Services, Strategy and Financial Analysis
    • 3M Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Becton Dickinson and Company
  • Reckitt Benckiser Group plc.
  • Ecolab Inc
  • Olympus Corporation
  • Miele Group
  • Biomerieux SA
  • Getinge AB
  • Halyard Health Inc.
  • Ansell Limited
  • Sotera Health LLC
  • Contec Inc.
  • Cantel Medical Corp.
  • Belimed AG
  • Nanosonics Limited
  • Advanced Sterilization Products Services Inc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年医院感染控制市场：提供新机会的国家
  • 2029年医院感染控制市场：细分领域带来新机会
  • 2029年医院感染控制市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r26568

Hospital-acquired infections, acquired during hospital care and absent before admission, are managed through hospital-acquired infection control, employing cleaning, sterilization, and disinfection methods to reduce or eliminate transmission. These infections may stem from cross-contamination involving equipment surfaces, patient skin, and healthcare staff. The goal of hospital-acquired infection control is to curb the spread of illnesses.

The primary types of products in hospital-acquired infection control encompass sterilizers, disinfectors, endoscope reprocessors, microbial testing instruments, reagents, consumables, disinfectants, infection prevention and surveillance software, and others. Sterilizers, machines designed to thoroughly cleanse and eliminate bacteria, are employed to kill germs on surfaces or in fluids, preventing disease transmission. Various technologies, including phenotypic and genotypic methods, address diseases such as hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections, and others. Applications range from disease testing to drug-resistance testing, with end users including hospitals, ICUs, ambulatory surgical and diagnostic centers, nursing homes, maternity centers, and others.

The hospital-acquired infection control market research report is one of a series of new reports from The Business Research Company that provides hospital-acquired infection control market statistics, including hospital-acquired infection control industry global market size, regional shares, competitors with a hospital-acquired infection control market share, detailed hospital-acquired infection control market segments, market trends and opportunities, and any further data you may need to thrive in the hospital-acquired infection control industry. This hospital-acquired infection control market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hospital-acquired infection control market size has grown steadily in recent years. It will grow from $34.59 billion in 2024 to $35.86 billion in 2025 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to increasing antibiotic resistance, growing awareness, stringent regulations, globalization of infectious diseases, patient safety initiatives.

The hospital-acquired infection control market size is expected to see strong growth in the next few years. It will grow to $44.42 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to rise of multidrug-resistant pathogens, pandemic preparedness, increased surveillance and monitoring, antimicrobial stewardship programs, international collaboration. Major trends in the forecast period include adoption of real-time location systems (RTLS), integration of artificial intelligence (AI) for surveillance, shift towards single-use and disposable devices, emphasis on staff training and education, increased utilization of disinfection technologies.

The hospital-acquired infection control market is anticipated to experience growth driven by the surge in COVID-19 cases. COVID-19, caused by the SARS-CoV-2 virus, has led to an increased demand for infection control products and services, emphasizing personal hygiene and the production of medical supplies. As of August 8, 2022, global COVID-19 cases reached 581.6 million, according to the World Health Organization, underscoring the market's expansion due to the ongoing pandemic.

Rising healthcare expenditures are expected to drive the growth of the hospital-acquired infection control market. Healthcare expenditures encompass the total spending on healthcare services, products, and activities within a defined timeframe, whether at the individual, community, national, or global level. As healthcare spending increases, hospitals and healthcare facilities are likely to allocate more resources toward adopting advanced infection prevention technologies. This includes innovative solutions such as advanced disinfection systems, smart monitoring devices, and other technologies that enhance overall infection control measures. For example, in May 2024, the Office for National Statistics, a UK-based government agency, reported a 5.6% increase in total healthcare expenditure in nominal terms between 2022 and 2023, compared to a mere 0.9% growth in 2022. Consequently, the rising healthcare expenditure is poised to fuel the growth of the hospital-acquired infection control market in the future.

Leading companies in the hospital-acquired infection control market are concentrating on creating new technological solutions, such as AI systems aimed at the early identification of sepsis to improve patient outcomes through prompt diagnosis and treatment. An AI system designed to assist in recognizing sepsis refers to advanced technological solutions that employ artificial intelligence and machine learning algorithms to detect initial signs of sepsis in patients. For example, in April 2024, Prenosis Inc., a US-based medical clinic, obtained FDA marketing authorization for the Sepsis ImmunoScore, the first AI-driven system created to predict sepsis, a potentially life-threatening condition that can result in serious complications. This innovative tool enhances early detection by analyzing real-time data, enabling healthcare professionals to respond more quickly and effectively. The integration of AI is intended to support medical staff in their decision-making processes rather than replace them, ultimately leading to improved patient outcomes and reduced healthcare costs.

Major companies in the hospital-acquired infection control market are obtaining regulatory approvals to launch innovative products and technologies aimed at decreasing the incidence of infections within healthcare environments. Regulatory approvals refer to the authorizations granted by government agencies or regulatory bodies that permit a company to market and sell its products or services. For example, in May 2023, Innoviva Specialty Therapeutics, a US-based biopharmaceutical company, received approval for the new treatment Xacduro (sulbactam and durlobactam), which is designed for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by specific strains of the Acinetobacter baumannii-calcoaceticus complex. This approval addresses the growing problem of antimicrobial resistance, particularly concerning Acinetobacter species. Xacduro combines sulbactam, which is effective against A. Common side effects may include abnormalities in liver function tests. The drug was granted several designations to expedite its development and review, underscoring its importance in treating severe bacterial infections in healthcare settings.

In August 2024, MicroCare, LLC, a US-based company that develops and manufactures cleaning and disinfecting products for the medical sector, acquired ICT Infection Control Technologies for an undisclosed amount. This acquisition allows MicroCare to enhance its healthcare portfolio by integrating ICT's specialized infection control solutions into its existing range of cleaning and lubrication products. This strategic move aims to strengthen MicroCare's position in the rapidly expanding medical infection prevention market, thereby improving the safety and effectiveness of cleaning solutions for healthcare facilities. ICT Infection Control Technologies is a US-based company that focuses on manufacturing infection control chemistries primarily for the dental and medical sectors.

Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schulke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.

North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hospital-acquired infection control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hospital-acquired infection control market includes revenues earned by entities by heat sterilization equipment, low temperature sterilization equipment, radiation sterilization equipment, other sterilization equipment, contract sterilization services, sterilization consumables and accessories, disinfectants, and disinfectors equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hospital-Acquired Infection Control Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hospital-acquired infection control market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hospital-acquired infection control ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hospital-acquired infection control market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
  • 2) By Technology: Phenotypic Methods; Genotypic Methods
  • 3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
  • 4) By Application: Disease Testing; Drug-Resistance Testing
  • 5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
  • Subsegments:
  • 1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
  • 2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
  • 3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
  • 4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
  • 5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
  • 6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
  • 7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
  • 8) By Other Products: Cleaning Equipment; Air Purification Systems
  • Companies Mentioned: Johnson and Johnson; P&G Professional; Honeywell International Inc.; MMM Group; 3M Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hospital-Acquired Infection Control Market Characteristics

3. Hospital-Acquired Infection Control Market Trends And Strategies

4. Hospital-Acquired Infection Control Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hospital-Acquired Infection Control Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hospital-Acquired Infection Control PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hospital-Acquired Infection Control Market Growth Rate Analysis
  • 5.4. Global Hospital-Acquired Infection Control Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hospital-Acquired Infection Control Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hospital-Acquired Infection Control Total Addressable Market (TAM)

6. Hospital-Acquired Infection Control Market Segmentation

  • 6.1. Global Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterilizers
  • Disinfectors
  • Endoscope Reprocessors
  • Microbial Testing Instruments
  • Consumables
  • Disinfectants
  • Infection Prevention And Surveillance Software
  • Other Products
  • 6.2. Global Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phenotypic Methods
  • Genotypic Methods
  • 6.3. Global Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Acquired Pneumonia
  • Bloodstream Infections
  • Surgical Site Infections
  • Gastrointestinal Infections
  • Urinary Tract Infection
  • Other Diseases
  • 6.4. Global Hospital-Acquired Infection Control Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Testing
  • Drug-Resistance Testing
  • 6.5. Global Hospital-Acquired Infection Control Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • ICUs
  • Ambulatory Surgical
  • Diagnostic Centers
  • Nursing Homes
  • Maternity Centers
  • Other End Users
  • 6.6. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Sterilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Steam Sterilizers
  • Ethylene Oxide Sterilizers
  • Hydrogen Peroxide Sterilizers
  • 6.7. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Disinfectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Washer Disinfectors
  • Automated Disinfectors
  • 6.8. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Endoscope Reprocessors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Level Disinfection Reprocessors
  • Automated Endoscope Reprocessors
  • 6.9. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Microbial Testing Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Culture Systems
  • Rapid Microbial Testing Systems
  • 6.10. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sterilization Wraps
  • Filters
  • Personal Protective Equipment (PPE)
  • 6.11. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Disinfectants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Alcohol-based Disinfectants
  • Chlorine-based Disinfectants
  • Quaternary Ammonium Compounds
  • 6.12. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Infection Prevention And Surveillance Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surveillance Software Solutions
  • Data Management Software
  • 6.13. Global Hospital-Acquired Infection Control Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cleaning Equipment
  • Air Purification Systems

7. Hospital-Acquired Infection Control Market Regional And Country Analysis

  • 7.1. Global Hospital-Acquired Infection Control Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hospital-Acquired Infection Control Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hospital-Acquired Infection Control Market

  • 8.1. Asia-Pacific Hospital-Acquired Infection Control Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hospital-Acquired Infection Control Market

  • 9.1. China Hospital-Acquired Infection Control Market Overview
  • 9.2. China Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hospital-Acquired Infection Control Market

  • 10.1. India Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hospital-Acquired Infection Control Market

  • 11.1. Japan Hospital-Acquired Infection Control Market Overview
  • 11.2. Japan Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hospital-Acquired Infection Control Market

  • 12.1. Australia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hospital-Acquired Infection Control Market

  • 13.1. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hospital-Acquired Infection Control Market

  • 14.1. South Korea Hospital-Acquired Infection Control Market Overview
  • 14.2. South Korea Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hospital-Acquired Infection Control Market

  • 15.1. Western Europe Hospital-Acquired Infection Control Market Overview
  • 15.2. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hospital-Acquired Infection Control Market

  • 16.1. UK Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hospital-Acquired Infection Control Market

  • 17.1. Germany Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hospital-Acquired Infection Control Market

  • 18.1. France Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hospital-Acquired Infection Control Market

  • 19.1. Italy Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hospital-Acquired Infection Control Market

  • 20.1. Spain Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hospital-Acquired Infection Control Market

  • 21.1. Eastern Europe Hospital-Acquired Infection Control Market Overview
  • 21.2. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hospital-Acquired Infection Control Market

  • 22.1. Russia Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hospital-Acquired Infection Control Market

  • 23.1. North America Hospital-Acquired Infection Control Market Overview
  • 23.2. North America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hospital-Acquired Infection Control Market

  • 24.1. USA Hospital-Acquired Infection Control Market Overview
  • 24.2. USA Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hospital-Acquired Infection Control Market

  • 25.1. Canada Hospital-Acquired Infection Control Market Overview
  • 25.2. Canada Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hospital-Acquired Infection Control Market

  • 26.1. South America Hospital-Acquired Infection Control Market Overview
  • 26.2. South America Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hospital-Acquired Infection Control Market

  • 27.1. Brazil Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hospital-Acquired Infection Control Market

  • 28.1. Middle East Hospital-Acquired Infection Control Market Overview
  • 28.2. Middle East Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hospital-Acquired Infection Control Market

  • 29.1. Africa Hospital-Acquired Infection Control Market Overview
  • 29.2. Africa Hospital-Acquired Infection Control Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hospital-Acquired Infection Control Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hospital-Acquired Infection Control Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hospital-Acquired Infection Control Market Competitive Landscape And Company Profiles

  • 30.1. Hospital-Acquired Infection Control Market Competitive Landscape
  • 30.2. Hospital-Acquired Infection Control Market Company Profiles
    • 30.2.1. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. P&G Professional Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Honeywell International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MMM Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3M Company Overview, Products and Services, Strategy and Financial Analysis

31. Hospital-Acquired Infection Control Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Reckitt Benckiser Group plc.
  • 31.3. Ecolab Inc
  • 31.4. Olympus Corporation
  • 31.5. Miele Group
  • 31.6. Biomerieux SA
  • 31.7. Getinge AB
  • 31.8. Halyard Health Inc.
  • 31.9. Ansell Limited
  • 31.10. Sotera Health LLC
  • 31.11. Contec Inc.
  • 31.12. Cantel Medical Corp.
  • 31.13. Belimed AG
  • 31.14. Nanosonics Limited
  • 31.15. Advanced Sterilization Products Services Inc

32. Global Hospital-Acquired Infection Control Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hospital-Acquired Infection Control Market

34. Recent Developments In The Hospital-Acquired Infection Control Market

35. Hospital-Acquired Infection Control Market High Potential Countries, Segments and Strategies

  • 35.1 Hospital-Acquired Infection Control Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hospital-Acquired Infection Control Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hospital-Acquired Infection Control Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer